Ureteroscope Market Size & Growth Forecast 2027–2036, By Segments (Product, Usability, End Use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Ureteroscope Market size was around USD 1.32 billion in 2026 and is slated to grow at a 6.36% CAGR from 2027 to 2036, reaching USD 2.45 billion by 2036. The industry revenue for 2027 is assessed at USD 1.39 billion.
Get more details on this report
Request Free Sample ReportUreteroscope Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 49.29% of the market in 2026, benefiting from advanced healthcare infrastructure, established urology services, specialized treatment centers, and strong adoption of minimally invasive procedures.
- Asia Pacific is the fastest-growing region, supported by expanding healthcare infrastructure, rising access to specialized urological care, increasing kidney stone treatment needs, and wider adoption of minimally invasive procedures.
Segment Momentum
- Flexible ureteroscopes accounted for 69.5% of the market in 2026, supported by their maneuverability, access to anatomically challenging urinary tract areas, and suitability for minimally invasive stone management and other upper urinary tract procedures.
- Disposable ureteroscopes are the fastest-growing usability segment, driven by infection-control priorities and simpler device management. Their ready-to-use format eliminates reprocessing requirements and can streamline workflows while supporting consistent device performance during procedures.
Market Expansion Drivers
- Rising incidence of urological disorders increasing ureteroscopy use.
- Advancements in flexible and digital ureteroscopes.
- Healthcare infrastructure expansion in emerging markets.
Leading Market Participants
- Key players in the ureteroscope market include Boston Scientific (USA), Olympus (Japan), Richard Wolf (Germany), KARL STORZ (Germany), Stryker (USA), Medtronic (Ireland), Coloplast (Denmark), Cook Medical (USA), B. Braun (Germany), Pusen Medical (China).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.32 billion
- 2027 Estimated Market Size: USD 1.39 billion
- Projected Market Size: USD 2.45 billion by 2036
- Growth Forecast: 6.36% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Product (Flexible Ureteroscope) | Usability (Reusable Ureteroscopes) | End Use (Hospitals) | Application (Urolithiasis)
- Emerging Opportunity Segment: Product (Flexible Ureteroscope) | Usability (Disposable Ureteroscopes) | End Use (Ambulatory Surgical Centers) | Application (Urolithiasis)
Market Growth Drivers and Industry Trends
Rising incidence of urological disorders increasing ureteroscopy use
The increasing prevalence of urological disorders, including urinary stones and other conditions affecting the urinary tract, is driving demand for minimally invasive diagnostic and treatment procedures. Ureteroscopy enables physicians to visualize and access the urinary tract with limited surgical intervention, supporting its use across a broad range of urological procedures. Growing awareness of minimally invasive treatment options and the increasing need for effective management of urological conditions are consequently supporting the adoption of ureteroscopes.
Advancements in flexible and digital ureteroscopes
Technological advancements in flexible and digital ureteroscopes are improving visualization, maneuverability, and procedural precision during urological interventions. Enhanced imaging capabilities and improved instrument flexibility allow physicians to navigate complex anatomical structures more effectively while supporting accurate diagnosis and treatment. These developments are encouraging healthcare facilities to adopt advanced ureteroscopic systems and are contributing to the continued evolution of minimally invasive urological procedures.
Healthcare infrastructure expansion in emerging markets
The expansion of healthcare infrastructure in emerging markets is increasing access to specialized diagnostic and surgical procedures, including minimally invasive urological treatments. Investments in hospitals, specialty clinics, advanced medical equipment, and healthcare services are creating greater opportunities for the adoption of modern endoscopic technologies. As healthcare providers in these regions strengthen their diagnostic and treatment capabilities, demand for ureteroscopes is expected to benefit from improved access to specialized urological care.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising incidence of urological disorders increasing ureteroscopy use | 1.8% | Short term (≤ 2 yrs) | North America; Europe; Spillover: Asia Pacific | Medium | Moderate |
| Advancements in flexible and digital ureteroscopes | 1.6% | Medium term (2–5 yrs) | Asia Pacific; North America; Spillover: Europe | Low | Moderate |
| Healthcare infrastructure expansion in emerging markets | 1.4% | Long term (5+ yrs) | Asia Pacific; Latin America; Spillover: MEA | Medium | Slow |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America accounted for 49.29% share of the ureteroscope market in 2026, impelled by advanced healthcare infrastructure, established urology services, and strong adoption of minimally invasive surgical procedures. The regional market benefits from growing preference for endoscopic approaches that can reduce surgical trauma and support efficient treatment of urinary tract conditions. Continued improvements in visualization technologies, instrument design, and procedural techniques are contributing to broader clinical adoption of ureteroscopic procedures. Increasing awareness of minimally invasive treatment options, along with the presence of specialized urology centers and advanced diagnostic capabilities, is also supporting demand for ureteroscopes across hospitals and ambulatory care settings.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region in the ureteroscope market, spurred by improving healthcare infrastructure, rising access to specialized urological care, and increasing adoption of minimally invasive procedures. Growing healthcare expenditure and expansion of hospitals and surgical facilities are creating opportunities for wider utilization of advanced endoscopic equipment. The increasing prevalence of urinary tract disorders and kidney stone conditions is also contributing to demand for effective diagnostic and therapeutic procedures. In addition, improvements in physician training, healthcare technology adoption, and patient awareness are encouraging the use of ureteroscopic techniques across developing and developed markets in the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Advanced Stone CareThe U.S. market emphasizes sophisticated ureteroscopic procedures, with hospitals and urology centers prioritizing visualization quality, procedural efficiency, and compatibility with advanced stone-management workflows. Demand is supported by continued adoption of flexible and digital ureteroscopes as providers seek reliable performance across increasingly complex cases.
Germany 🇩🇪
Precision Urology AdoptionGermany places strong emphasis on precision, durability, and clinical workflow efficiency in ureteroscopy. Hospitals are likely to prioritize advanced imaging, dependable instrumentation, and compatibility with established endourology systems, while purchasing decisions remain attentive to clinical performance and long-term equipment value.
Japan 🇯🇵
Compact Procedure EfficiencyJapan's ureteroscope market is shaped by demand for dependable, minimally invasive stone-treatment solutions that support efficient procedures. Healthcare providers value precise visualization, maneuverability, and ergonomic instrument design, creating opportunities for technologies that integrate smoothly into established urological workflows and address increasingly sophisticated endoscopic procedures.
South Korea 🇰🇷
Digital Endoscopy IntegrationSouth Korea is strengthening the role of advanced visualization and minimally invasive techniques in urological care. Ureteroscope adoption is supported by hospitals seeking digital imaging capabilities, improved maneuverability, and procedural consistency, particularly where modern endourology platforms can enhance complex stone-management workflows.
France 🇫🇷
Hospital Workflow OptimizationFrance presents demand centered on efficient and reliable ureteroscopic care within hospital-based urology services. Providers are likely to favor instruments that combine high-quality visualization with manageable operating costs, supporting adoption of flexible technologies that can improve procedural versatility without disrupting established clinical workflows.
Italy 🇮🇹
Flexible Urology ExpansionItaly's market is supported by continued use of minimally invasive approaches for urinary stone management, with flexible ureteroscopes offering greater procedural versatility. Hospitals and specialist centers are likely to focus on maneuverability, image quality, and reusable or cost-efficient configurations that fit practical endourology requirements.
Ureteroscope Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Flexible Ureteroscope (Largest & Fastest-Growing Segment)
The flexible ureteroscope segment dominated the ureteroscope market, accounting for 69.5% market share in 2026, and is also expected to register the fastest growth over the forecast period. Its strong position is driven by the increasing adoption of minimally invasive approaches for the diagnosis and treatment of urinary tract conditions, where flexible ureteroscopes provide enhanced access to anatomically challenging areas of the urinary system. Their maneuverability and ability to navigate the ureter and reach the renal collecting system support a broad range of endourological procedures, including the management of urinary stones and other upper urinary tract conditions. Advances in visualization, instrument design, and procedural capabilities are further improving the clinical utility of flexible ureteroscopes and supporting their adoption across healthcare settings. In addition, the growing preference for procedures that can reduce surgical trauma, recovery time, and hospitalization requirements is strengthening demand for flexible ureteroscopic techniques. As healthcare providers increasingly prioritize precise visualization, procedural flexibility, and minimally invasive treatment options, flexible ureteroscopes are expected to maintain their leading position while experiencing strong expansion.
Usability Segment Analysis: Reusable Ureteroscopes (Largest Segment) vs Disposable Ureteroscopes (Fastest-Growing Segment)
Reusable ureteroscopes dominated the usability segment of the ureteroscope market, accounting for 74.4% market share in 2026. Their leading position is supported by their established role in hospitals and other healthcare facilities that perform ureteroscopic procedures regularly and require equipment capable of supporting repeated clinical use. Reusable ureteroscopes can provide healthcare providers with an established workflow for recurring procedures, while their integration into existing endourology infrastructure can support continued utilization across a broad range of cases. Healthcare facilities with consistent procedural volumes may also favor reusable systems as part of their long-term equipment strategies, particularly where dedicated reprocessing capabilities and trained personnel are available. Continued improvements in durability, visualization, maneuverability, and instrument performance are further supporting the utility of reusable ureteroscopes. As demand for minimally invasive urological procedures increases, established healthcare facilities are expected to continue relying on reusable systems for routine and complex interventions.
The disposable ureteroscope segment is expected to witness the fastest growth over the forecast period, driven by increasing attention to infection control, workflow efficiency, and the operational challenges associated with reprocessing reusable devices. Single-use ureteroscopes eliminate the need for post-procedure cleaning, sterilization, and maintenance, which can simplify procedural workflows and reduce concerns related to cross-contamination. Their availability as ready-to-use devices can also support greater consistency in device performance and visualization during procedures. Growing adoption of minimally invasive stone management and other ureteroscopic interventions is creating additional opportunities for disposable systems, particularly in healthcare environments seeking to streamline equipment handling. Improvements in disposable ureteroscope design, image quality, maneuverability, and overall procedural functionality are further strengthening their appeal. As healthcare providers place greater emphasis on infection prevention, operational efficiency, and simplified device management, disposable ureteroscopes are gaining increasing traction in the usability segment.
End Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
The hospitals segment dominated the end-use segment of the ureteroscope market in 2026, supported by the high concentration of urological procedures and specialized clinical infrastructure in hospital settings. Hospitals are equipped to manage a broad spectrum of urinary tract conditions, including cases requiring advanced diagnostic capabilities, complex interventions, and multidisciplinary care. The availability of specialized urology departments, operating facilities, imaging technologies, anesthesia services, and post-procedure monitoring supports the continued use of ureteroscopes in hospital-based care. Hospitals also serve patients with varying degrees of disease complexity, making them important centers for both routine and advanced ureteroscopic procedures. In addition, the increasing adoption of minimally invasive techniques for urinary stone management and other urological conditions is supporting demand for ureteroscopic equipment across hospital facilities. As healthcare systems expand access to specialized urological services and invest in advanced procedural infrastructure, hospitals are expected to remain a major end-use setting for ureteroscopes.
The ambulatory surgical centers segment is expected to witness the fastest growth over the forecast period, driven by the increasing shift toward outpatient and minimally invasive procedures. Ambulatory surgical centers can provide a more streamlined care environment for appropriately selected ureteroscopic interventions, allowing patients to undergo procedures without requiring extended hospital stays. The growing emphasis on reducing healthcare costs, improving resource utilization, and increasing procedural efficiency is encouraging the migration of suitable interventions toward outpatient settings. Advances in ureteroscope technology and procedural techniques are also expanding the range of cases that can be managed in ambulatory environments while supporting effective visualization and treatment. In addition, patient preference for convenient care pathways and shorter recovery periods is contributing to the growing role of ambulatory surgical centers in urological treatment. As healthcare providers continue to expand outpatient procedural capacity and adopt efficient minimally invasive workflows, demand for ureteroscopes in ambulatory surgical centers is expected to accelerate.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Flexible Ureteroscope, Rigid Ureteroscope | Flexible Ureteroscope | Flexible Ureteroscope |
| Usability | Reusable Ureteroscopes, Disposable Ureteroscopes | Reusable Ureteroscopes | Disposable Ureteroscopes |
| End Use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Application | Urolithiasis, Urethral Stricture, Urinary Tract Infections, Others | Urolithiasis | Urolithiasis |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
The ureteroscope market presents manufacturers with a multifaceted design challenge in which visualization, maneuverability, and instrument economics must be evaluated together. High-resolution digital imaging can improve anatomical visibility, but its practical value also depends on consistent image quality and integration into clinical workflows. Similarly, ergonomic controls and predictable deflection influence navigation and handling, while miniaturized insertion shafts must preserve durability, irrigation, and imaging functionality despite their reduced profile. These engineering priorities intersect with the choice between single-use and reusable devices, creating distinct economic considerations for healthcare providers. Although single-use systems can simplify instrument availability and eliminate reprocessing, reusable devices may spread acquisition costs across multiple procedures. Purchasing decisions therefore depend on clinical requirements, procedural volumes, infrastructure, and total cost of ownership rather than any single product attribute.
Major players in the ureteroscope market:
- Boston Scientific (USA)
- Olympus (Japan)
- Richard Wolf (Germany)
- KARL STORZ (Germany)
- Stryker (USA)
- Medtronic (Ireland)
- Coloplast (Denmark)
- Cook Medical (USA)
- B. Braun (Germany)
- Pusen Medical (China)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boston Scientific (USA) | |||||||
| Olympus (Japan) | |||||||
| Richard Wolf (Germany) | |||||||
| KARL STORZ (Germany) | |||||||
| Stryker (USA) | |||||||
| Medtronic (Ireland) | |||||||
| Coloplast (Denmark) | |||||||
| Cook Medical (USA) | |||||||
| B. Braun (Germany) | |||||||
| Pusen Medical (China) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Olympus | May 2026 | Olympus signed a definitive agreement to acquire BioProtect Ltd. for USD 270 million, expanding its urology and oncology portfolio and strengthening technologies used in prostate cancer procedures alongside its core endoscopy business. |
| Boston Scientific | March 2026 | Boston Scientific received US FDA 510(k) clearance for the Asurys Fluid Management System for endoscopic urologic procedures, including ureteroscopy. The system adds irrigation and real-time intrarenal pressure management to integrate with LithoVue Elite workflows. |
| Richard Wolf Medical Instruments Corporation | July 2024 | Richard Wolf Medical Instruments Corporation announced its D-URS single-use hybrid ureteroscope for presentation at the Vizient Innovative Technology Exchange, reflecting a competitive focus on disposable or hybrid configurations aimed at healthcare procurement channels. |
| Ambu A/S | June 2024 | Ambu received FDA 510(k) clearance for its ureteroscopy solution comprising the single-use aScope 5 Uretero and aBox 2 full-HD endoscopy system. The clearance supports a controlled U.S. market release and expands Ambu’s urology portfolio into ureteroscopy, targeting diagnostic and therapeutic procedures. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Ureteroscope Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Imaging Technology | Standard optical imaging, Digital imaging, High-definition digital imaging, Enhanced imaging technologies |
| Procedure Complexity | Routine procedures, Moderately complex procedures, Complex procedures, Advanced endourological procedures |
| Procedure Volume | Low-volume facilities, Medium-volume facilities, High-volume facilities, Very-high-volume facilities |
Ureteroscope Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Procedure Adoption & Clinical Workflow Evolution |
|
| Disposable Versus Reusable Scope Economics |
|
| Infection Control & Scope Selection |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the market valuation of the ureteroscope market?
What is the anticipated CAGR of the ureteroscope industry?
How are advances in flexible and digital ureteroscopes influencing healthcare adoption?
How is healthcare infrastructure expansion supporting ureteroscope adoption in emerging markets?
Why do flexible ureteroscopes dominate the ureteroscope market?
What is driving the growing adoption of disposable ureteroscopes?
What makes North America the leading market for ureteroscopes?
Why is the Asia Pacific ureteroscope market growing rapidly?
Which organizations are considered leaders in the ureteroscope landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook